A useful longevity stack is built in layers, not by collecting every supplement linked to aging. Start with resistance training, aerobic fitness, daily movement, adequate protein, a fiber-rich diet, sleep, metabolic health, and strong social ties. If you want one supplement with a clear additive job, creatine monohydrate has the strongest case in our current review.
Protein powder, omega-3, and prebiotic fiber are better treated as gap-closers. Collagen belongs in a structural-health lane. NMN and trans-resveratrol can sit later as advanced options. Vitamins and more specialized compounds should have a reason to be there.
The rule is simple: every item in your stack needs one clear job.
CELLSHE FRAMEWORK
The longevity stack in one view
| Layer | What belongs here | The job |
|---|---|---|
| 1. Foundation | Strength training, aerobic activity, movement, protein adequacy, plant-rich food, fiber, sleep, metabolic health, social health | Protect function and reduce major age-related health risks. |
| 2. Core supplement | Creatine monohydrate | Add to the physical-resilience work already created by training. |
| 3. Gap-closers | Protein powder, EPA+DHA, prebiotic fiber | Close a real nutrition or intake gap. |
| 4. Goal-specific | Collagen peptides | Support a defined skin, connective-tissue, joint, or structural goal. |
| 5. Advanced cellular | NMN, standardized trans-resveratrol | Add targeted cellular or cardiometabolic biology after the basics are covered. |
| 6. Needs-based | Vitamin D, magnesium, K2, multivitamin, CoQ10, berberine, curcumin, HMB, EAA/leucine | Address a dietary, clinical, medication, or goal-specific reason. |
| 7. Watch or skip | Emerging geroscience and weakly validated longevity categories | Wait for better human evidence before adding more complexity. |
CELLSHE synthesis of human outcome evidence, formulation relevance, redundancy, and practical use. The ordering is an editorial evidence hierarchy, not a clinical treatment guideline.
What is a longevity stack?
A longevity stack is the set of habits, nutrition choices, and selected supplements you combine to support healthy aging.
That definition is broader than the supplement aisle. A longevity supplement stack is only the product portion of that larger system. The distinction matters because the strongest interventions in healthy aging are not always products you can buy.
The scientific framework behind aging also points away from a bottle-per-pathway strategy. The 2023 Hallmarks of Aging update described 12 interconnected hallmarks. A 2025 geroscience framework expanded the working model to 14 by adding extracellular-matrix changes and psychosocial isolation.[1][2]
The important word is interconnected. You do not need 14 supplements because scientists can describe 14 areas of aging biology.
A better stack asks a harder question: what does this addition do that the rest of my routine does not already do? If you want the broader ingredient-by-ingredient evidence review instead, see which longevity supplements are actually worth considering.
Start with the part of the stack you cannot buy
For a woman in midlife, the foundation is where much of the highest-value work happens.
Resistance training protects physical capacity
Strength, muscle, power, and the ability to perform daily tasks become more important as the years pass. Resistance training improves muscle function, muscle size, and physical performance across a large randomized-trial evidence base.[3]
If you want a practical program, our strength-training guide for longevity turns the evidence into two full-body sessions each week.
Keep aerobic fitness and daily movement too
Lifting does not replace walking, cycling, swimming, running, or other aerobic work. Cardiorespiratory fitness and resistance training protect different parts of physical capacity.
The stack is stronger when both are present. Daily movement also matters outside planned workouts.
Protein, dietary quality, and fiber come before powders
Adequate protein supports muscle maintenance and adaptation to training. A protein supplement can help, but the nutrient itself belongs in the foundation.
The same logic applies to fiber. A plant-rich eating pattern and adequate dietary fiber do more than another supplement.
Sleep, metabolic health, and social health belong in the stack
Sleep disruption, poor metabolic health, and social isolation can shape how well you function in midlife.
Our Aging Well After 40 field guide brings these foundation pieces together in one practical plan.
What about fasting or time-restricted eating? Treat it as a conditional tool, not a longevity requirement. For women protecting muscle and bone in midlife, an eating window is useful only if it still allows adequate nutrition, protein, and training recovery.
If you add one core supplement, creatine has the strongest case
Creatine monohydrate earns the first supplement position because it has a clear job: help support strength and lean-tissue gains, especially alongside resistance training.
That is a more useful reason than saying creatine "targets mitochondria" or belongs to a particular anti-aging pathway.
A 2025 meta-analysis of eight randomized trials in 482 older adults found that adding creatine to resistance training improved lower-limb strength and lean tissue compared with training plus placebo.[4]
The women-specific evidence is now stronger too. A 2026 meta-analysis included seven randomized trials and 608 postmenopausal women. Creatine produced an additional average lean-mass gain of 0.37 kg and improved leg-press strength by 7.5 kg. The clearest results appeared when at least 5 g per day was paired with resistance training.[5]
Bone density did not improve overall in that review. That makes the role easier to define: creatine belongs here for physical resilience, not because it has to solve every part of aging.
Protein, omega-3, and fiber are gap-closers
Three useful supplement categories often get treated as universal daily requirements. We think that is the wrong test.
The better question is whether each product closes a gap you actually have.
CELLSHE DECISION TOOL
Do I actually need this?
| Option | Its job | When it earns a place | When food may already cover it |
|---|---|---|---|
| Protein powder | Make adequate high-quality protein easier to reach. | Your meals regularly fall short, appetite is lower, or convenience improves consistency. | You already reach an adequate protein intake through normal meals. |
| Omega-3 EPA+DHA | Add the long-chain omega-3s most often studied in cardiometabolic research. | Your fish or seafood intake is low, or a clinician has identified a reason for supplementation. | You regularly eat adequate oily fish or otherwise meet your EPA+DHA needs. |
| Prebiotic fiber | Increase fermentable substrate and help close a fiber gap. | Food intake is low, regularity is a problem, or a tolerated fiber product makes adequate intake easier. | Your diet already provides plenty of varied plant fiber and you tolerate it well. |
Protein-supplement evidence is strongest when it improves total protein intake or complements training. Prebiotic effects depend on the exact substrate, dose, population, and outcome.[6][8]
Protein powder is convenience, not a separate longevity nutrient
A 2024 network meta-analysis of randomized trials in older adults found that nutrition plus resistance training can improve muscle outcomes, with protein strategies among the more useful approaches.[6]
That does not mean everyone needs a shake. If breakfast, lunch, and dinner already get the job done, another powder adds little unique value.
Omega-3 can be useful without becoming an aging-clock product
EPA and DHA have a large human evidence base in cardiovascular and triglyceride biology. Their place should come from that broader evidence and your dietary context.
A 2025 DO-HEALTH analysis also found small changes in several DNA-methylation aging measures with 1 g per day of omega-3 over three years.[7] That result is interesting. A change in an epigenetic clock is still a biomarker result, not proof that a person aged more slowly.
Prebiotic fiber makes more sense than a generic "longevity probiotic"
A 2025 meta-analysis of 29 randomized trials in 1,633 adults aged 60 and older found that prebiotic, probiotic, and synbiotic interventions could change selected gut microbes and inflammatory markers.[8]
The important distinction is that a probiotic is not one active ingredient. Strain, dose, formulation, carrier, and population all matter.
For a general stack, closing a fiber gap is a more defensible starting point than buying an unspecified collection of bacteria because the label says "microbiome."
Collagen belongs in a different lane: structural aging
Collagen can earn a place when your goal is structural, such as skin, connective tissue, joints, or selected musculoskeletal outcomes.
A 2026 umbrella review pooled 16 systematic reviews covering 113 randomized trials and 7,983 participants. Across skin, musculoskeletal health, and osteoarthritis outcomes, collagen supplementation showed a real but bounded evidence base.[9]
This is also where the expanded geroscience framework becomes useful. Extracellular-matrix changes were added to the 2025 working model of aging biology.[2]
That does not turn collagen into a whole-body geroprotector. It gives structural health a place in the conversation that it deserves.
If we eventually formulate collagen at CELLSHE, the peptide source, studied dose, and intended structural job will matter more than putting "longevity" on the front label.
Where NMN and resveratrol fit now
NMN and trans-resveratrol still belong in our longevity framework, but later than training, nutrition, and physical resilience.
They earn that position for different reasons. They should not be squeezed into one invented synergy story.
NMN is an advanced NAD-pathway option
NMN is a precursor used in NAD+ biosynthesis. Human trials repeatedly show biochemical target engagement, including a 60-day dose-ranging randomized trial in healthy middle-aged adults.[19]
A 2026 systematic review of NAD-related interventions found that oral NMN and NR reliably changed NAD-related biomarkers in humans. Effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were more variable and often endpoint-specific.[10]
That is enough for NMN to remain a credible advanced layer. It is not a reason to move it above strength, protein adequacy, or cardiometabolic foundations.
Resveratrol has more human evidence than the old SIRT1 story suggests
Resveratrol is a plant polyphenol with a large randomized-trial literature. Its case does not depend on claiming that it directly switches on SIRT1.
A 2026 umbrella review included 45 systematic reviews and 68 health outcomes. High-certainty evidence supported reductions in waist circumference, total cholesterol in overweight adults, and systolic and diastolic blood pressure in people with type 2 diabetes. Moderate-certainty evidence covered several metabolic, endothelial, inflammatory, and other outcomes.[11]
Those are population-specific findings, but they are meaningful human evidence. Resveratrol does not need to be sold as a universal anti-aging switch to justify further interest.
For women specifically, our Resveratrol for Women guide looks at the direct female evidence, including menopause, dosage, brain blood flow, estrogen, safety, and fertility.
Form matters. "Resveratrol" on a front label does not tell you how much is the predominant, more studied trans isomer. Purity, standardization, dose, and formulation should be stated clearly. Our trans-resveratrol guide shows how to read that distinction on a label.
Should you take NMN and resveratrol together?
They can reasonably coexist in the same routine because they are different compounds with different evidence bases. Human trials have not shown that the NMN-plus-resveratrol combination outperforms either ingredient alone.
That is the useful answer. You do not need to invent biochemical synergy to put two independently chosen ingredients in the same routine.
Our dedicated guide to NMN and resveratrol together goes deeper into the pair without turning mechanism into combination proof.
Why direct oral NAD+ no longer makes our core stack
We would not make conventional direct oral NAD+ a default longevity-stack component today.
The evidence did change in 2026, and that change is worth representing accurately. A randomized trial of a proprietary physicochemically modified oral NAD+ formulation called LNAD+ found a 53% increase in intracellular whole-blood NAD after five days. Plasma NAD did not rise, and no secondary clinical or wellbeing endpoint remained significant after correction for multiple testing.[12]
That is useful target-engagement evidence for one formulation. It does not establish that standard oral NAD+ capsules as a category deliver the same result.
For a broader comparison of the routes and precursor evidence, see our guide to NAD+ supplements.
The needs-based layer: useful does not mean universal
Many supplements can be valuable in the right situation. That is different from saying every healthy woman should add them to a longevity protocol.
CELLSHE DECISION TABLE
When a supplement needs a reason
| Intervention | When it may earn a place | Why it is not automatic |
|---|---|---|
| Vitamin D | Low status, limited intake/exposure, bone-health plan, or clinician-directed use. | Routine supplementation in replete adults does not become a longevity intervention simply because vitamin D is essential. In VITAL, 2,000 IU per day did not reduce fractures in generally healthy midlife and older adults not selected for deficiency.[17] |
| Magnesium | Low intake, a relevant clinical indication, or a formulation chosen for a defined goal. | Benefits depend heavily on baseline status, population, outcome, and dose. A 2025 meta-analysis found larger blood-pressure effects in people with hypertension or hypomagnesemia than in normotensive groups.[18] |
| Vitamin K2 | A clinician-guided bone-health strategy in the right person. | Evidence does not justify universal use, and anticoagulant therapy changes the safety discussion. |
| Multivitamin-mineral | Dietary adequacy insurance when intake is inconsistent or individual needs justify it. | It is a broad adequacy tool, not a replacement for a good diet. COSMOS found modest cognitive benefits in older adults, not a general anti-aging effect.[13] |
| Berberine | Selected metabolic-risk contexts with professional input. | Much of the favorable evidence comes from metabolically at-risk populations, and interaction burden is more relevant than with a basic nutrient. |
| CoQ10 / curcumin | Defined disease, medication, joint, fatigue, or inflammatory contexts where formulation-specific evidence applies. | Disease-specific or formulation-specific results should not be generalized into a universal healthy-aging recommendation. |
| HMB / EAA / leucine | Frailty, sarcopenia, low intake, rehabilitation, or another muscle-specific reason. | Adequate complete protein plus resistance training usually solves the more general problem first. |
What we are watching, but would not build around yet
A research watchlist is useful because it stops every interesting molecule from becoming tomorrow morning's capsule.
- Urolithin A: a 2022 randomized trial in 66 adults aged 65 to 90 improved selected muscle-endurance measures, while its prespecified 6-minute walk and maximal ATP-production outcomes were not significantly better than placebo.[20] Larger and more independent clinical evidence would strengthen the case.
- Taurine: worth following, including a small randomized trial in women aged 55 to 70, but current healthy-aging evidence remains too small and biomarker-heavy for a core role.[14]
- GlyNAC: promising early multi-domain results, followed by a larger short trial that did not improve its primary glutathione endpoint.
- Spermidine: elegant autophagy biology, but a 12-month randomized trial in 100 older adults did not improve its primary cognitive outcome.[15]
- NR: works as an NAD precursor, but it is largely redundant if NMN already fills that job in the stack.
- Cocoa flavanols: vascular biology is interesting, while the large COSMOS trial did not significantly reduce its primary total cardiovascular endpoint.[16]
We would also leave fisetin, Ca-AKG, generic probiotic blends, and quercetin marketed as a proven human senolytic out of the current core stack. The evidence can change. The stack should change when it does.
The hallmarks are a map, not a shopping list
The hallmarks of aging are valuable because they prevent us from thinking about healthy aging as one pathway.
Exercise can influence physical function, metabolism, inflammation, mitochondrial biology, and intercellular signaling. Diet and fiber connect to metabolic health and the gut ecosystem. Collagen has a much narrower structural job. NMN is closely tied to NAD biology. Resveratrol has selected cardiometabolic and polyphenol evidence.
Those relationships are useful for checking whether a strategy is biologically narrow. They are not evidence that each intervention "reverses" a hallmark in humans.
Our rule is to use the hallmarks as a coverage audit. We do not use them to manufacture reasons for buying more supplements.
That is also why there is no telomere pill in this stack, no generic senolytic slot, and no requirement to fill every box.
Build your own longevity stack in five decisions
The useful part of a stack is not knowing 30 ingredient names. It is being able to decide what deserves to stay.
PRINTABLE
The CELLSHE Longevity Stack Builder
☐ Resistance training ☐ Aerobic activity ☐ Daily movement ☐ Adequate protein
☐ Plant-rich diet/fiber ☐ Sleep ☐ Metabolic health ☐ Social/mental health
| Item | Its one job | Human evidence for that job | Already covered elsewhere? | Decision |
|---|---|---|---|---|
| Strong / Moderate / Early | Yes / No | Keep / Review / Remove | ||
| Strong / Moderate / Early | Yes / No | Keep / Review / Remove | ||
| Strong / Moderate / Early | Yes / No | Keep / Review / Remove | ||
| Strong / Moderate / Early | Yes / No | Keep / Review / Remove | ||
| Strong / Moderate / Early | Yes / No | Keep / Review / Remove |
☐ I checked for duplicate nutrients. ☐ I checked medication interactions. ☐ I checked whether my condition, pregnancy/nursing status, or upcoming procedure changes the decision.
This worksheet is an educational decision aid, not a diagnostic tool or individualized medical plan.
What would we prioritize today?
For a generally healthy woman in midlife, we would build the stack in this order:
- Build the foundation: resistance training, aerobic fitness, daily movement, adequate protein, plant-rich food and fiber, sleep, metabolic health, and social health.
- Add creatine monohydrate: the clearest core supplement for physical resilience in our current review.
- Close real gaps: use protein powder, EPA+DHA, or prebiotic fiber when diet or context gives them a job.
- Add collagen for a defined structural goal: not because every longevity stack needs collagen.
- Consider NMN and trans-resveratrol later: advanced options with credible human evidence in narrower domains.
- Keep nutrients and specialized compounds needs-based: add them because you have a reason, not because a protocol screenshot told you to.
A good longevity stack can become smaller as your thinking gets better. The goal is not the longest routine. It is a routine where every layer earns its place.
Disclosure: CELLSHE sells creatine monohydrate, NMN, and resveratrol products discussed in this article. Product status did not determine the evidence hierarchy.
Scientific references
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349. PubMed.
- Kroemer G, Maier AB, Cuervo AM, et al. From geroscience to precision geromedicine: Understanding and managing aging. Cell. 2025;188(8):2043-2062. PMID: 40250404. PubMed.
- Currier BS, D'Souza AC, Fiatarone Singh MA, et al. American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Med Sci Sports Exerc. 2026;58(4):851-872. PMID: 41843416. Full text.
- Liu S, Huang N, Wu W, et al. The impact of creatine supplementation associated with resistance training on muscular strength and lean tissue mass in the aged: a systematic review and meta-analysis. Eur Rev Aging Phys Act. 2025;22(1):26. PMID: 41388441. Full text.
- Naddafha S, Antonio J, Kreider RB, Stout JR. Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. J Int Soc Sports Nutr. 2026;23(1):2668435. PMID: 42141930. Full text.
- Liao CD, Huang SW, Chen HC, et al. Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials. Nutrients. 2024;16(7):941. PMID: 38612975. Full text.
- Bischoff-Ferrari HA, Gängler S, Wieczorek M, et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat Aging. 2025;5:376-385. PMID: 39900648. Full text.
- Zhuang K, Luo H, et al. Effects of probiotics, prebiotics, and synbiotics on gut microbiota in older adults: a systematic review and meta-analysis of randomized controlled trials. Nutr J. 2025;24:147. PMID: 41023690. Full text.
- Ravindran R, Pizzol D, López-Gil JF, et al. Collagen Supplementation for Skin and Musculoskeletal Health: An Umbrella Review of Meta-Analyses on Elasticity, Hydration, and Structural Outcomes. Aesthet Surg J Open Forum. 2026;8:ojag018. PMID: 41809116. Full text.
- Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026;116:103057. PMID: 41655607. PubMed.
- Sun JN, Yang R, Fang L, et al. Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials. Nutr J. 2026;25:63. PMID: 41987155. PubMed.
- Kornilov SA, et al. Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. GeroScience. 2026. PMID: 42530810. PubMed.
- Vyas CM, Manson JE, Sesso HD, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the COSMOS randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692-701. PMID: 38244989. Full text.
- Abud GF, de Carvalho FG, Batitucci G, et al. Taurine as a possible antiaging therapy: A controlled clinical trial on taurine antioxidant activity in women ages 55 to 70. Nutrition. 2022;101:111706. PMID: 35700594. PubMed.
- Schwarz C, Benson GS, Horn N, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(5):e2213875. PMID: 35616942. Full text.
- Sesso HD, Manson JE, Aragaki AK, et al. Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COSMOS randomized clinical trial. Am J Clin Nutr. 2022;115(6):1490-1500. PMID: 35294962. Full text.
- LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med. 2022;387:299-309. PMID: 35939577. PubMed.
- Argeros Z, Xu X, Bhandari B, et al. Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension. 2025;82(11):1844-1856. PMID: 41000008. Full text.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. PMID: 36482258. Full text.
- Liu S, D'Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(1):e2144279. PMID: 35050355. Full text.
